Pharmaceuticals: Reporting season in the US: read-across for the European players under coverage
PharmaceuticalsReporting season in the US: read-across for the European players under coverage
Merck surprisingly bearish about Covid-19’s impacts over business
Pfizer more in line with peers in the industry
Eliquis and Lynparza report solid growth, Ibrance decelerates
TIGIT, the new class to watch in oncology?
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.